UBS Group AG - ANI PHARMACEUTICALS INC ownership

ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 126 filers reported holding ANI PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 2.71 and the average weighting 0.2%.

Quarter-by-quarter ownership
UBS Group AG ownership history of ANI PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$358,695
-79.2%
6,178
-80.7%
0.00%
-100.0%
Q2 2023$1,726,490
+271.6%
32,073
+174.2%
0.00%
Q1 2023$464,605
+69.4%
11,697
+71.6%
0.00%
Q4 2022$274,248
+27324.8%
6,817
+15393.2%
0.00%
Q3 2022$1,000
-92.9%
44
-90.9%
0.00%
Q1 2022$14,000
-94.9%
481
-91.8%
0.00%
Q4 2021$273,000
+415.1%
5,901
+262.7%
0.00%
Q3 2021$53,000
-36.1%
1,627
-31.1%
0.00%
Q2 2021$83,000
-42.4%
2,360
-40.4%
0.00%
Q1 2021$144,000
-0.7%
3,963
-20.6%
0.00%
Q4 2020$145,000
-35.8%
4,993
-37.4%
0.00%
Q3 2020$226,000
-61.1%
7,981
-55.6%
0.00%
Q2 2020$581,000
+86.8%
17,990
+136.2%
0.00%
Q1 2020$311,000
-66.8%
7,617
-49.9%
0.00%
Q4 2019$937,000
+32.7%
15,195
+57.1%
0.00%
Q3 2019$706,000
+100.0%
9,674
+125.5%
0.00%
Q2 2019$353,000
+4312.5%
4,290
+3475.0%
0.00%
Q1 2019$8,000
-20.0%
120
-45.0%
0.00%
Q4 2018$10,000
-89.9%
218
-87.6%
0.00%
Q3 2018$99,000
+120.0%
1,754
+162.2%
0.00%
Q2 2018$45,000
-48.9%
669
-55.5%
0.00%
Q1 2018$88,000
+363.2%
1,504
+408.1%
0.00%
Q4 2017$19,000
-87.1%
296
-89.4%
0.00%
Q3 2017$147,000
+40.0%
2,792
+25.0%
0.00%
Q2 2017$105,000
-53.9%
2,234
-51.6%
0.00%
Q1 2017$228,000
-45.5%
4,612
-33.1%
0.00%
Q4 2016$418,000
-67.3%
6,899
-64.2%
0.00%
-100.0%
Q3 2016$1,280,000
+57.6%
19,287
+32.7%
0.00%0.0%
Q2 2016$812,000
+1149.2%
14,539
+654.9%
0.00%
Q1 2016$65,000
-26.1%
1,926
-1.5%
0.00%
Q4 2015$88,000
+4300.0%
1,955
+3213.6%
0.00%
Q3 2015$2,000
-99.6%
59
-99.3%
0.00%
Q2 2015$537,000
+215.9%
8,649
+218.1%
0.00%
Q1 2015$170,000
+304.8%
2,719
+262.5%
0.00%
Q4 2014$42,0007500.00%
Other shareholders
ANI PHARMACEUTICALS INC shareholders Q3 2022
NameSharesValueWeighting ↓
FIRST WILSHIRE SECURITIES MANAGEMENT INC 367,754$10,911,0004.08%
AIGH Capital Management LLC 244,500$7,254,0001.91%
Parkman Healthcare Partners LLC 108,559$3,221,0001.19%
Worth Venture Partners, LLC 60,831$1,927,0001.13%
Global Alpha Capital Management Ltd. 323,731$9,605,0001.04%
Mesirow Financial Investment Management, Inc. 6,892$204,0000.99%
MARATHON CAPITAL MANAGEMENT 74,460$2,209,0000.71%
EMERALD ADVISERS, LLC 455,880$13,526,0000.70%
EMERALD MUTUAL FUND ADVISERS TRUST 356,865$10,588,0000.61%
Jackson Creek Investment Advisors LLC 32,698$1,120,0000.45%
View complete list of ANI PHARMACEUTICALS INC shareholders